Lupin Limited
Lupin Limited has informed the Exchange regarding a press release dated October 23, 2026, titled "Lupin Appoints Brian Savage as President, Chief Legal Officer".
Filed with NSE · ISIN INE326A01029 ·
6ix is reading this filing.
View original source (NSE India)Lupin Limited on 6ix
Story so far
- Lupin Limited has informed the Exchange regarding a press release dated October 08, 2026, titled "Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USP".
- Lupin Limited has informed the Exchange regarding a press release dated October 06, 2026, titled "Lupin Launches Formoflo-G® MDI, World s First Fixed-dose Triple Combination Drug for COPD Management".
Earlier from Lupin
- Lupin Limited has informed the Exchange regarding a press release dated October 08, 2026, titled "Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USP".
- Lupin Limited has informed the Exchange regarding a press release dated October 06, 2026, titled "Lupin Launches Formoflo-G® MDI, World s First Fixed-dose Triple Combination Drug for COPD Management".
- Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
- Lupin Limited Press Release Sep 28 2026
- Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin